Eager for Entry to Diagnostics Arena, Sequenom Publishes the First of Its Genome-Scan Studies | GenomeWeb

In the first published study from its genome-scan genetic association strategy, Sequenom is looking to change its luck.

The company hopes its research, which reports the discovery of polymorphisms in intercellular adhesion molecule genes linked to a greater risk of breast or prostate cancer, will help it attract a compatible suitor capable of helping it develop a prognostic or diagnostic test based on its work.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Startup companies are taking on personalized medicine, CNET reports.

Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.

The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.

In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.